BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

903 related articles for article (PubMed ID: 9568807)

  • 21. Relationship between the growth hormone/insulin-like growth factor-I axis, insulin sensitivity, and adrenal androgens in normal prepubertal and pubertal girls.
    Guercio G; Rivarola MA; Chaler E; Maceiras M; Belgorosky A
    J Clin Endocrinol Metab; 2003 Mar; 88(3):1389-93. PubMed ID: 12629134
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serum melatonin in central precocious puberty is lower than in age-matched prepubertal children.
    Waldhauser F; Boepple PA; Schemper M; Mansfield MJ; Crowley WF
    J Clin Endocrinol Metab; 1991 Oct; 73(4):793-6. PubMed ID: 1909703
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Suppression of sex steroids by a gonadotrophin-releasing hormone agonist increases serum growth hormone-binding protein activity in girls with central idiopathic precocious puberty.
    Kobayashi Y; Murata A; Yasuda T; Minagawa M; Wataki K; Ohnishi H; Niimi H
    Clin Endocrinol (Oxf); 1994 Mar; 40(3):351-5. PubMed ID: 8187298
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gonadotrophin and prolactin secretory dynamics in girls with normal puberty, idiopathic precocious puberty and precocious puberty due to hypothalamic hamartoma.
    Uriarte MM; Klein KO; Barnes KM; Pescovitz OH; Loriaux DL; Cutler GB
    Clin Endocrinol (Oxf); 1998 Sep; 49(3):363-8. PubMed ID: 9861328
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Presentation and evolution of organic central precocious puberty according to the type of CNS lesion.
    Trivin C; Couto-Silva AC; Sainte-Rose C; Chemaitilly W; Kalifa C; Doz F; Zerah M; Brauner R
    Clin Endocrinol (Oxf); 2006 Aug; 65(2):239-45. PubMed ID: 16886967
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment of true precocious puberty with a potent luteinizing hormone-releasing factor agonist: effect on growth, sexual maturation, pelvic sonography, and the hypothalamic-pituitary-gonadal axis.
    Styne DM; Harris DA; Egli CA; Conte FA; Kaplan SL; Rivier J; Vale W; Grumbach MM
    J Clin Endocrinol Metab; 1985 Jul; 61(1):142-51. PubMed ID: 3923027
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adrenal steroid secretion in girls with pseudoprecocious puberty due to autonomous ovarian cysts.
    Chasalow FI; Granoff AB; Tse TF; Blethen SL
    J Clin Endocrinol Metab; 1986 Oct; 63(4):828-34. PubMed ID: 3018024
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Use of a potent, long acting agonist of gonadotropin-releasing hormone in the treatment of precocious puberty.
    Boepple PA; Mansfield MJ; Wierman ME; Rudlin CR; Bode HH; Crigler JF; Crawford JD; Crowley WF
    Endocr Rev; 1986 Feb; 7(1):24-33. PubMed ID: 2937629
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serum levels of type I procollagen C-terminal propeptide, insulin-like growth factor-I (IGF-I), and IGF binding protein-3 in obese children and adolescents: relationship to gender, pubertal development, growth, insulin, and nutritional status.
    Falorni A; Bini V; Cabiati G; Papi F; Arzano S; Celi F; Sanasi M
    Metabolism; 1997 Aug; 46(8):862-71. PubMed ID: 9258266
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The NIH experience with precocious puberty: diagnostic subgroups and response to short-term luteinizing hormone releasing hormone analogue therapy.
    Pescovitz OH; Comite F; Hench K; Barnes K; McNemar A; Foster C; Kenigsberg D; Loriaux DL; Cutler GB
    J Pediatr; 1986 Jan; 108(1):47-54. PubMed ID: 3080571
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Five-day pulsatile gonadotropin-releasing hormone administration unveils combined hypothalamic-pituitary-gonadal defects underlying profound hypoandrogenism in men with prolonged critical illness.
    van den Berghe G; Weekers F; Baxter RC; Wouters P; Iranmanesh A; Bouillon R; Veldhuis JD
    J Clin Endocrinol Metab; 2001 Jul; 86(7):3217-26. PubMed ID: 11443192
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term effectiveness of depot gonadotropin-releasing hormone analogue in the treatment of children with central precocious puberty.
    Clemons RD; Kappy MS; Stuart TE; Perelman AH; Hoekstra FT
    Am J Dis Child; 1993 Jun; 147(6):653-7. PubMed ID: 8506834
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The relationship between ovarian structure and serum insulin, insulin-like growth factor-I (IGF-I) and its binding protein (IGFBP-1 and IGFBP-3) levels in premature pubarche.
    Teixeira RJ; Silva VC; Gazolla HM; Cunha SB; Guimarães MM
    J Pediatr Endocrinol Metab; 2002 Jan; 15(1):69-75. PubMed ID: 11826868
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hydrocortisone treatment in girls with congenital adrenal hyperplasia inhibits serum dehydroepiandrosterone sulfate and affects the GH-IGF-I system.
    Guercio G; Rivarola MA; Chaler E; Maceiras M; Belgorosky A
    J Pediatr Endocrinol Metab; 2009 Mar; 22(3):255-61. PubMed ID: 19492582
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The alteration of IGF-1 levels and relationship between IGF-1 levels and growth velocity during GnRH analogue therapy.
    Muratoglu Sahin N; Peltek Kendirci HN; Çetinkaya S; Savaş Erdeve Ş; Aycan Z
    J Pediatr Endocrinol Metab; 2020 Jan; 33(1):113-120. PubMed ID: 31809263
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of growth hormone replacement therapy on IGF-related parameters and on the pituitary-gonadal axis in GH-deficient males. A double-blind, placebo-controlled crossover study.
    Juul A; Andersson AM; Pedersen SA; Jørgensen JO; Christiansen JS; Groome NP; Skakkebaek NE
    Horm Res; 1998; 49(6):269-78. PubMed ID: 9623518
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Effects of Chinese herbal medicine on modulating the course of puberty development in children with precocious puberty].
    Cai DP; Chen BY; Zhang W; Li P
    Zhong Xi Yi Jie He Xue Bao; 2006 Mar; 4(2):166-74. PubMed ID: 16529694
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Changes in serum insulin-like growth factor I (IGF-I) and IGF-binding protein-3 levels during growth hormone treatment in prepubertal short children born small for gestational age.
    Boguszewski M; Jansson C; Rosberg S; Albertsson-Wikland K
    J Clin Endocrinol Metab; 1996 Nov; 81(11):3902-8. PubMed ID: 8923836
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Etiology and clinical features of isosexual precocious puberty in Taiwanese girls: twenty-three years' experience in National Taiwan University Hospital.
    Lee CT; Tung YC; Tsai WY
    J Pediatr Endocrinol Metab; 2009 Oct; 22(10):947-53. PubMed ID: 20020583
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The pubertal growth spurt in eight patients with true precocious puberty and growth hormone deficiency: evidence for a direct role of sex steroids.
    Attie KM; Ramirez NR; Conte FA; Kaplan SL; Grumbach MM
    J Clin Endocrinol Metab; 1990 Oct; 71(4):975-83. PubMed ID: 2401720
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 46.